-
Mayo Clinic Discovery Leads to FDA Approval for Stem Cell Trial for Heart Failure Patients
Share this:
U.S. FDA Approves Phase III Cardiopoietic Stem Cell Trial for Heart Failure Patients Based on a Mayo Discovery
Cardio3 BioSciences, an international Mayo Clinic collaborator, has received FDA approval for a phase III pivotal clinical trial of its stem cell therapy. The trial will test the Mayo Clinic discovery of cardiopoietic (cardiogenically-instructed) stem cells designed to improve heart health in people suffering from heart failure. The multisite U.S. trial, called CHART-2, will aim to recruit 240 patients with chronic advanced symptomatic heart failure. Cardio3 BioSciences is a bioscience company in Mont-Saint-Guibert, Belgium.
"Regenerative medicine is poised to transform the way we treat patients," says Andre Terzic, M.D., Ph.D., director of the Mayo Clinic Center for Regenerative Medicine. Watch the video below to see how stem cells are being used to treat people with heart failure.
Journalists: Video b-roll of today's news conference, plus sound bites with Dr. Terzic and Christian Homsy, M.D., CEO of Cardio3 BioSciences, are available in the downloads. The video pkg. is also available in the downloads in MOV format.
https://www.youtube.com/watch?v=vumB_FW_fTA
Share this:
Related articles
Menopause can bring on an array of symptoms from hot flashes and night sweats to weight gain. But can it cause problems with memory? Mayo Clinic's Dr. ...
Women experience menopause at different ages — and different ways — which can, among other things, affect their heart health. The average age of natural menopause ...
Menopause marks the end of reproductive years. Fluctuating hormonal levels can lead to a variety of unwanted symptoms, including hot flashes, night sweats and sleep ...